Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma

BACKGROUND: Inhibition of the renin–angiotensin system (RAS) was associated with longer survival in patients with different solid malignancies. OBJECTIVE: The objective of this study was to investigate the effect of RAS inhibitor (RASi) treatment (angiotensin-converting enzyme inhibitors or angioten...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:United European Gastroenterol J
Autors principals: Pinter, Matthias, Weinmann, Arndt, Wörns, Marcus-Alexander, Hucke, Florian, Bota, Simona, Marquardt, Jens U, Duda, Dan G, Jain, Rakesh K, Galle, Peter R, Trauner, Michael, Peck-Radosavljevic, Markus, Sieghart, Wolfgang
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5676550/
https://ncbi.nlm.nih.gov/pubmed/29163965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640617695698
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars